French Tribune Novartis, Cytos Alzheimer's vax shows immune response FierceVaccines CAD106, a vaccine co-developed by Novartis and Cytos that targets the amyloid β peptide, has shown early hints of immune responses in a clinical trial in … Early steps toward an Alzheimer's vaccine Harvard Health Publications (blog) all 34 news articles
Click here for more interesting articles
Tags: Immune support